PROPERTIES OF LYMPHOID TUMOR CELLS IN VIVO AND IN VITRO
PROPERTIES OF LYMPHOID TUMOR CELLS IN VIVO AND IN VITRO
批准号:
6666022
负责人:
VINCENT K TSIAGBE
金额:
$7.58万
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
已结题
起止时间:
1976-05-01 至 2003-12-31
关键词:
B lymphocyte T cell receptor T lymphocyte apoptosis carcinogenesis cytokine gene expression genetically modified animals host neoplasm interaction human tissue laboratory mouse lymphoma neoplasm /cancer transplantation neoplastic growth nucleic acid sequence oncogenes surface antigens tumor antigens
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The host T cell germinal center (GC) derived B lymphoma cell interaction
will be examined. A central question to be answered about the
lymphomagenesis in SJL mice is: What causes the high mtv-29 encoded
vSAg transcription and how does it relate to the GC origin of these
lymphomas (RCS)? The 5' LTR of mtv-29 in liver and RCS DNA will be
sequenced to determine whether the 5'LTR is defective in all cells or only
in RCS cells to explain that the vSAg initiation site is in the end region
mtv-29. Regulation of the expression of this vSAg will be studied by using
transection of reporter constructs and looking for specific binding factors
for regions in mtv-29, expressed in RCS and normal GC but not in other
B cells. The mechanism of the growth promotion in vivo will be studies,
including the fate of vbeta16+ T cells in c57L mice will be analyzed. The
vbeta16 T cell representation in PBL of mice with developing primary
lymphomas will be followed and the effect of anti-vbeta16 on tumor growth
in vivo evaluated. Attempts will be made to identify secondary oncogenic
events that cause continued proliferation and a lack of differentiation in
e
lymphoma cells. It will be determined whether RCS, normal isolated GC
and NJ101 cells differ in resistance to spontaneous and glucocorticosteroid
induced apoptosis. The expression of several oncogenes in morphologically
abnormal and normal GCs from bcl-2 transgenic and normal SJL mice will
be studies. To evaluate whether the phenomenon of ~reverse immune
surveillance~ may be applicable to humans, CD4+ T cell infiltrates in
human GC-derived lymphomas will be examined for Vbeta or Va TCR
patterns that might reflect monoclonal responses to specific Ag or v beta
restricted responses to a SAg.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Characterization of SJL T cell clones responsive to syngeneic lymphoma (RCS): RCS-specific clones are stimulated by activated B cells.
对同基因淋巴瘤 (RCS) 作出反应的 SJL T 细胞克隆的特征:RCS 特异性克隆受到激活的 B 细胞的刺激。
DOI:
--
发表时间:
1985
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[DeKruyff,RH, Brown,PH, Thorbecke,GJ, Ponzio,NM]
通讯作者:
Ponzio,NM
Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
SJL 淋巴瘤的特征和生长因子需求。
DOI:
10.1002/eji.1830190222
发表时间:
1989
期刊:
European journal of immunology
影响因子:
5.4
作者:
[Lasky,JL, Thorbecke,GJ]
通讯作者:
Thorbecke,GJ
DOI:
10.1016/s1521-6616(03)00043-3
发表时间:
2003-06
期刊:
Clinical immunology
影响因子:
8.6
作者:
[H. Li;Xun Ma;T. Moskovits;G. Inghirami;V. Tsiagbe]
通讯作者:
H. Li;Xun Ma;T. Moskovits;G. Inghirami;V. Tsiagbe
Host-tumor interactions in the SJL lymphoma model.
SJL 淋巴瘤模型中宿主与肿瘤的相互作用。
DOI:
10.3109/08830188609056610
发表时间:
1986
期刊:
International reviews of immunology
影响因子:
5
作者:
[Ponzio,NM, Brown,PH, Thorbecke,GJ]
通讯作者:
Thorbecke,GJ
Characterization of a (BALB/c x C57BL/6)F1 T cell hybridoma with double specificity: recognition of antigen in context of I-Ad and autoreactivity to I-Ab.
具有双重特异性的 (BALB/c x C57BL/6)F1 T 细胞杂交瘤的表征:在 I-Ad 背景下识别抗原以及对 I-Ab 的自身反应。
DOI:
10.1002/eji.1830140713
发表时间:
1984
期刊:
European journal of immunology
影响因子:
5.4
作者:
[Nagase,F, Waters,SJ, Thorbecke,GJ, Bona,CA]
通讯作者:
Bona,CA
共 29 条
Unraveling germinal center B cell lymphoma development
-
批准号:7259337
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2004
-
负责人:VINCENT K TSIAGBE
-
依托单位:
Unraveling germinal center B cell lymphoma development
-
批准号:6775749
-
项目类别:
-
资助金额:$31.18万
-
财政年份:2004
-
负责人:VINCENT K TSIAGBE
-
依托单位:
Unraveling germinal center B cell lymphoma development
-
批准号:6872476
-
项目类别:
-
资助金额:$31.18万
-
财政年份:2004
-
负责人:VINCENT K TSIAGBE
-
依托单位:
Unraveling germinal center B cell lymphoma development
-
批准号:7024987
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2004
-
负责人:VINCENT K TSIAGBE
-
依托单位:
PROPERTIES OF LYMPHOID TUMOR CELLS IN VIVO AND IN VITRO
-
批准号:6341817
-
项目类别:
-
资助金额:$38.3万
-
财政年份:1976
-
负责人:VINCENT K TSIAGBE
-
依托单位:
海外基金